As health systems and physician groups marshal resources to launch their own plans, they must consider whether they have the necessary building blocks to successfully make the leap, how integrated a model they will pursue and whether they will build, buy or partner strategy.
As health systems and physician groups marshal resources to launch their own plans, they must consider whether they have the necessary building blocks to successfully make the leap, how integrated a model they will pursue and whether they will build, buy or partner strategy.
There are more than 165,000 health- and wellness-related apps for iOS, but overall engagement remains low outside the top 10. To best benefit users, who should be responsible for health and wellness apps-employers, healthcare insurers or individual consumers? It depends.
There are more than 165,000 health- and wellness-related apps for iOS, but overall engagement remains low outside the top 10. To best benefit users, who should be responsible for health and wellness apps-employers, healthcare insurers or individual consumers? It depends.
The two PCSK9 inhibitors have fallen far short of expectations. Inclisiran, which works by RNA inference, only needs to be injected twice a year.
Despite different drivers among healthcare leaders, telehealth is gaining momentum. Still, key barriers need to be addressed.
Artificial intelligence is about to do what we hoped to see technology do in the last decade for the health industry: Empower organizations and clinicians to improve the health, outcomes, and experience of care for more people in less time and at lower cost.
Five generations make up the nation’s current workforce and differences exist in each one. Here’s a multi-faceted approach employers can take to engage a multi-generational workforce in their healthcare benefits.
Why cost and treatment length are some of the biggest concerns for drug manufacturers.
Healthcare organizations should focus on these things to improve health management of COPD patients and reduce costs.
CMS’ Quality Payment Program launched in 2016 as part of MACRA. Here’s what’s in store for Year 2.
Will President-elect Donald Trump affect the outcome of the Anthem-Cigna and Aetna-Humana mergers?
Here are the top three reasons for medication adherence failure and how to overcome them.
Creating a comprehensive customer experience doesn’t happen overnight, but the key to achieving it comes from taking a “bone deep” approach.
By addressing the root problem of obesity with structured programs, providers can help patients lose weight and very possibly avoid expensive chronic illnesses as a result. Employers and payers should incentivize healthy weight by paying for obesity care and treatment, potentially reaping substantial savings in the long term.
Following the GOP’s success on Election Day, the nation is quickly tuning in to what this all means for healthcare coverage.
The path to bundled payment success can be daunting. Here’s three universal concepts that will promote success under the various CMS models.
Many aspects of the ACA have been assimilated into the healthcare system. Will a Trump administration undo them?
We have a path to ending the HIV epidemic in the United States, but it requires health plans and healthcare purchasers to take a more active role in getting us there.
Medicare plans must understand the impact of CMS rule change to be prepared for risk adjustment in 2017. Here are 10 tips to better manage the risk adjustment process.
Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.
Explore how using support tools can prevent treatment overutilization.
Telephonic and personalized diabetes self-education programs which fit into patient’s busy lives will make a greater impact than in-person classes only.
While the second feed may not change providers’ actions in terms of the strategy they’re implementing for the Comprehensive Care for Joint Replacement program, the findings should change their expectations.
Adding non-opioid postsurgical options to hospital formularies should be a top consideration.
Deaths due to opioid abuse have risen sharply-and show no signs of leveling off. Here’s how data analytics can prevent abuse and diversion.
Although CMS released the final rule for MACRA in October, there is still quite a bit of confusion.
Here’s what managed healthcare executives should keep an eye on moving into the new year.
By deploying a proactive, year-round strategy that aligns data analytics with a focused approach for addressing gaps in care, your organization can turn routine quality measurement and reporting activities into a true strategic advantage by ensuring that quality measurably improves across key metrics.
Here’s what managed healthcare executives should keep an eye on moving into the new year.